We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immutep and Eddingpharm Start Production of ImmuFact® IMP321

News   Apr 15, 2014

 
Immutep and Eddingpharm Start Production of ImmuFact® IMP321
 
 
 

RELATED ARTICLES

Our Microbiome Is What We Eat

News

A high-quality diet is linked to more potentially beneficial bacteria in the gut; while a low-quality diet is associated with an increase in potentially harmful bacteria. Modifying the microbiome through diet may therefore be part of a strategy to reduce the risk of chronic diseases.

READ MORE

Cellular Pathway Tied to Cancer

News

Scientists have discovered a cellular pathway tied to cancer that may be helpful for reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.

READ MORE

Uncovering Chemo-resistance in Cancer

News

Some cancers do not respond to treatment with one of the most effective chemotherapy drugs: 5-Fluorouracil (5-FU) – now we know why.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE